CLINTEC
LIVE

Serial Number

79100249

Owner

Clintec International Limited

Attorney

Arlene D. Hanks

Filing Date

Mar 8, 2011

Add to watchlist:

No watchlists yet
View on USPTO

CLINTEC Trademark

Serial Number: 79100249 • Registration: 4162941

CLINTEC is a trademark filed by Clintec International Limited on March 8, 2011. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Clintec International Limited

133 Finnieston Street
Glasgow G3 8HB , GB

Entity Type: 99

Trademark Details

Filing Date

March 8, 2011

Registration Date

June 26, 2012

Published for Opposition

April 10, 2012

Goods & Services

[ Educational and ] training services in the field of clinical trials regulation and clinical research; [ Providing, arranging and conducting workshops, seminars, and educational conferences in the field of clinical trials regulation and clinical research; ] training in data capture and management; training [ and education ] in regulatory affairs; [ Providing, arranging and conducting training and educational classes, workshops, seminars, and education conferences in medical writing; providing, arranging and conducting training and educational classes, workshops, seminars, and education conferences training and education in quality control, auditing and inspection; writing of texts; ] training services, namely, training of clinical and scientific researchers to conduct clinical research and drug development studies

Business consultation in the field of clinical research [ and pharmaceutical commercialisation; ] compilation and systemization of information into computer databases; database management for others of a database comprised of data collected for clinical and biostatistics research purposes; personnel recruitment and placement in the field of clinical research; compilation and provision of statistical analysis reports; [ statistical consulting services for pharmaceutical, biotechnology and medical device industries for business purposes; ] creation and implementation of statistical analysis plans for business purposes; writing of business reports; business strategic planning [ ; market research, assessment, analysis and evaluation; business feasibility studies ]

[ Advisory and consultancy services relating to regulatory affairs in the field of clinical trials, clinical research and drug development; ] advisory and consultancy services relating to national and international regulation of clinical trials and drug development

Scientific and technological services and research and design in the field of clinical trials and clinical research; industrial analysis and research services in the field of clinical trials and clinical research; clinical research services, namely, implementation of clinical studies and providing reports thereon; [ management of scientific research projects; conducting clinical research projects in the field of clinical trials and clinical research; ] conducting and monitoring clinical trials [ ; quality audit services, quality assurance consultancy, quality control testing in the field of quality control for others; technical inspection services, namely, inspection of clinical data, clinical procedure, clinical process, clinical database, and clinical reports for others; pharmaceutical product evaluation; design and conducting of technical feasibility studies; drug development services; quality management of drug development; preparation of reports in relation to clinical trials and clinical research, including preparation of reports on management of scientific research projects, clinical research projects, clinical trials, audits, pharmaceutical product evaluations, drug development and pharmaceutical product evaluations ]

Filing History

PARTIAL INVALIDATION PROCESSED BY THE IB
Mar 17, 2024 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 3, 2024 INPS
INVALIDATION PROCESSED
Feb 2, 2024 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 24, 2024 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 24, 2023 NA71
REGISTERED-SEC.71 ACCEPTED
May 24, 2023 71AG
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
May 22, 2023 EROP
POST REGISTRATION ACTION MAILED - SEC.71
Dec 22, 2022 PR71
POST REGISTRATION ACTION CORRECTION
Dec 22, 2022 XXXX
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 22, 2022 APRE
TEAS SECTION 71 RECEIVED
Jun 29, 2022 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Jun 26, 2021 REM4
INTERNATIONAL REGISTRATION RENEWED
Mar 25, 2021 RNWL
NEW REPRESENTATIVE AT IB RECEIVED
Jan 22, 2021 NREP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 15, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 15, 2019 REAP
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Dec 2, 2017 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Dec 2, 2017 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 1, 2017 APRE
TEAS SECTION 71 & 15 RECEIVED
Nov 3, 2017 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 26, 2017 REM3
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 28, 2014 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 28, 2014 REAP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 6, 2013 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 6, 2013 REAP
NOTIFICATION PROCESSED BY IB
Dec 2, 2012 GPNX
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 15, 2012 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 26, 2012 FICS
FINAL DISPOSITION PROCESSED
Sep 26, 2012 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 26, 2012 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 26, 2012 R.PR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
May 17, 2012 CORR
CORRECTION TRANSACTION RECEIVED FROM IB
May 11, 2012 CRCV
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 10, 2012 NPUB
PUBLISHED FOR OPPOSITION
Apr 10, 2012 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 4, 2012 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 4, 2012 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 21, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 5, 2012 PREV
ASSIGNED TO LIE
Feb 29, 2012 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 11, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 10, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 10, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 10, 2012 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 18, 2011 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 18, 2011 REAP
REFUSAL PROCESSED BY IB
Aug 27, 2011 RFNP
APPLICATION FILING RECEIPT MAILED
Aug 11, 2011 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 10, 2011 RFCS
REFUSAL PROCESSED BY MPU
Aug 10, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 10, 2011 RFCR
NON-FINAL ACTION WRITTEN
Aug 9, 2011 CNRT
ASSIGNED TO EXAMINER
Aug 8, 2011 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 7, 2011 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 4, 2011 REPR